Jeremy Rosenblum1, Juan Lin, Mimi Kim, Adam S Levy. 1. Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Bronx, NY 10467, USA. jrosenbl@montefiore.org
Abstract
BACKGROUND: Febrile neutropenia is a common reason for the hospitalization of pediatric oncology patients. The initiation of antibiotics and the overall decline in rates of bacteremia, would predict a low yield of detection of bacteremia in repeated blood cultures. Despite little evidence supporting the utility of serial cultures, repeat culturing with fever persists. PROCEDURE: To determine the rate of follow-up blood culture growth when the initial blood culture showed no bacterial growth and patient risk factors for this occurrence, we reviewed the records of oncology patients admitted to the Children's Hospital at Montefiore Pediatric Hematology/Oncology service for febrile neutropenia from 2004 to 2009. RESULTS: We identified 457 febrile neutropenia episodes in 137 patients. The initial blood culture was positive in 84 episodes (18.4%). In 220 episodes comprising 105 patients, the initial blood culture was negative and a subsequent culture was obtained. In 24 episodes (10.9%), bacterial growth was detected in the repeat culture. Risk factors included a previous history of bacteremia and hospitalization for more than 48 hours prior to onset of fever. CONCLUSIONS: In patients with febrile neutropenia, bacteremia is detected nearly twice as frequently in initial blood cultures than in repeat blood cultures obtained when the initial blood culture is negative. Despite an initial negative blood culture, bacteremia can be detected in more than 10% of episodes when a repeat blood culture is obtained. The risk more than doubles for patients with a previous history of bacteremia or hospitalized for more than 48 hours prior to the onset of fever.
BACKGROUND:Febrile neutropenia is a common reason for the hospitalization of pediatric oncology patients. The initiation of antibiotics and the overall decline in rates of bacteremia, would predict a low yield of detection of bacteremia in repeated blood cultures. Despite little evidence supporting the utility of serial cultures, repeat culturing with fever persists. PROCEDURE: To determine the rate of follow-up blood culture growth when the initial blood culture showed no bacterial growth and patient risk factors for this occurrence, we reviewed the records of oncology patients admitted to the Children's Hospital at Montefiore Pediatric Hematology/Oncology service for febrile neutropenia from 2004 to 2009. RESULTS: We identified 457 febrile neutropenia episodes in 137 patients. The initial blood culture was positive in 84 episodes (18.4%). In 220 episodes comprising 105 patients, the initial blood culture was negative and a subsequent culture was obtained. In 24 episodes (10.9%), bacterial growth was detected in the repeat culture. Risk factors included a previous history of bacteremia and hospitalization for more than 48 hours prior to onset of fever. CONCLUSIONS: In patients with febrile neutropenia, bacteremia is detected nearly twice as frequently in initial blood cultures than in repeat blood cultures obtained when the initial blood culture is negative. Despite an initial negative blood culture, bacteremia can be detected in more than 10% of episodes when a repeat blood culture is obtained. The risk more than doubles for patients with a previous history of bacteremia or hospitalized for more than 48 hours prior to the onset of fever.
Authors: F R Cockerill; J W Wilson; E A Vetter; K M Goodman; C A Torgerson; W S Harmsen; C D Schleck; D M Ilstrup; J A Washington; W R Wilson Journal: Clin Infect Dis Date: 2004-05-25 Impact factor: 9.079
Authors: P A Pizzo; K J Robichaud; F A Gill; F G Witebsky; A S Levine; A B Deisseroth; D L Glaubiger; J D Maclowry; I T Magrath; D G Poplack; R M Simon Journal: Am J Med Date: 1979-08 Impact factor: 4.965
Authors: M E Santolaya; A M Alvarez; A Becker; J Cofré; N Enríquez; M O'Ryan; E Payá; J Pilorget; C Salgado; J Tordecilla; M Varas; M Villarroel; T Viviani; M Zubieta Journal: J Clin Oncol Date: 2001-07-15 Impact factor: 44.544
Authors: J S Serody; M M Berrey; K Albritton; S M O'Brien; E P Capel; S H Bigelow; D J Weber; J M Wiley; M J Schell; P H Gilligan; T C Shea Journal: Bone Marrow Transplant Date: 2000-09 Impact factor: 5.483
Authors: María E Santolaya; Ana M Alvarez; Carmen L Avilés; Ana Becker; José Cofré; Miguel A Cumsille; Miguel L O'Ryan; Ernesto Payá; Carmen Salgado; Pamela Silva; Juan Tordecilla; Mónica Varas; Milena Villarroel; Tamara Viviani; Marcela Zubieta Journal: J Clin Oncol Date: 2004-09-15 Impact factor: 44.544
Authors: Aditya H Gaur; Mary Anne Giannini; Patricia M Flynn; Jan W Boudreaux; Mark A Mestemacher; Jerry L Shenep; Randall T Hayden Journal: Pediatr Infect Dis J Date: 2003-06 Impact factor: 2.129
Authors: Rachel L Wattier; Christopher C Dvorak; Andrew D Auerbach; Peggy S Weintrub Journal: Pediatr Blood Cancer Date: 2015-03-01 Impact factor: 3.167
Authors: Julia R Spinardi; Rodrigo Berea; Patricia A Orioli; Marina M Gabriele; Alessandra Navarini; Marina T Marques; Milton N Neto; Marcelo J Mimica Journal: Germs Date: 2017-06-01
Authors: Naima A Al-Mulla; Saad J Taj-Aldeen; Sittana El Shafie; Mohammed Janahi; Abdullah A Al-Nasser; Prem Chandra Journal: Infect Drug Resist Date: 2014-11-06 Impact factor: 4.003
Authors: Max Scheler; Thomas Lehrnbecher; Andreas H Groll; Ruth Volland; Hans-Jürgen Laws; Roland A Ammann; Philipp Agyeman; Andishe Attarbaschi; Margaux Lux; Arne Simon Journal: Infection Date: 2020-06-10 Impact factor: 3.553